Total Payments
$2,259
2023 Payments
$135.11
Companies
22
Transactions
127
Medicare Patients
6,038
Medicare Billing
$714,235
Payment Breakdown by Category
Food & Beverage$2,105 (93.2%)
Education$154.42 (6.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,105 | 122 | 93.2% |
| Education | $154.42 | 5 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $425.91 | 49 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $378.33 | 18 | $0 (2019) |
| Amgen Inc. | $200.50 | 5 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $162.37 | 5 | $0 (2017) |
| Medtronic, Inc. | $135.11 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $128.53 | 12 | $0 (2017) |
| Astellas Pharma US Inc | $106.00 | 2 | $0 (2017) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $100.23 | 2 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $97.77 | 5 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $97.51 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $135.11 | 1 | Medtronic, Inc. ($135.11) |
| 2019 | $197.61 | 5 | Amgen Inc. ($121.75) |
| 2018 | $539.82 | 32 | E.R. Squibb & Sons, L.L.C. ($185.06) |
| 2017 | $1,387 | 89 | E.R. Squibb & Sons, L.L.C. ($204.99) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2023 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $135.11 | General |
| Category: Pacemakers | ||||||
| 04/22/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.75 | General |
| Category: Cardiology | ||||||
| 03/01/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Cardiovascular | ||||||
| 02/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/07/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: Cardiovascular | ||||||
| 01/04/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: Cardiovascular | ||||||
| 12/14/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.44 | General |
| Category: Cardiovascular | ||||||
| 12/10/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.00 | General |
| Category: Cardiovascular | ||||||
| 11/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.62 | General |
| Category: Cardiovascular | ||||||
| 11/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.85 | General |
| Category: Cardiovascular | ||||||
| 11/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.69 | General |
| Category: Cardiovascular | ||||||
| 11/14/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $92.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/08/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $3.62 | General |
| Category: Cardiovascular | ||||||
| 10/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: Cardiovascular | ||||||
| 10/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.37 | General |
| Category: Cardiovascular | ||||||
| 10/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.85 | General |
| Category: Cardiovascular | ||||||
| 10/15/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $81.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.19 | General |
| Category: Cardiovascular | ||||||
| 09/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.71 | General |
| Category: Cardiovascular | ||||||
| 09/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.49 | General |
| Category: Cardiovascular | ||||||
| 09/11/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.21 | General |
| Category: Cardiovascular | ||||||
| 08/31/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.47 | General |
| Category: Cardiovascular | ||||||
| 08/01/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.49 | General |
| Category: Cardiovascular | ||||||
| 07/25/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.50 | General |
| Category: Cardiovascular | ||||||
| 07/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.35 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,464 | 2,039 | $840,086 | $175,869 |
| 2022 | 16 | 1,285 | 1,850 | $704,493 | $166,362 |
| 2021 | 18 | 1,809 | 2,555 | $912,793 | $211,934 |
| 2020 | 19 | 1,480 | 2,072 | $734,618 | $160,070 |
Total Patients
6,038
Total Services
8,516
Medicare Billing
$714,235
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 562 | $150,616 | $52,678 | 35.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 314 | 319 | $339,735 | $48,095 | 14.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 57 | 57 | $70,338 | $21,399 | 30.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 57 | 114 | $52,352 | $10,943 | 20.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 144 | $26,496 | $9,265 | 35.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 43 | 172 | $18,748 | $7,647 | 40.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 50 | $16,650 | $5,188 | 31.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 25 | 25 | $15,075 | $4,022 | 26.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 64 | 65 | $26,585 | $3,494 | 13.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 220 | 235 | $21,150 | $2,597 | 12.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 30 | 30 | $15,360 | $1,687 | 11.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,320 | $1,664 | 38.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 30 | 30 | $34,736 | $1,663 | 4.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 16 | $4,224 | $1,612 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,080 | $1,427 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,980 | $1,143 | 23.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 120 | 127 | $12,813 | $828.85 | 6.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $17,669 | $374.76 | 2.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 15 | 15 | $2,583 | $90.00 | 3.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 20 | 20 | $1,576 | $51.00 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 585 | $156,780 | $56,436 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 254 | 256 | $272,640 | $41,450 | 15.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 44 | 44 | $54,296 | $17,707 | 32.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 46 | 91 | $33,215 | $9,025 | 27.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 41 | 164 | $17,876 | $7,964 | 44.5% |
About Dr. Robert Sackstein, M.D
Dr. Robert Sackstein, M.D is a Cardiovascular Disease healthcare provider based in Trumbull, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407855927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Sackstein, M.D has received a total of $2,259 in payments from pharmaceutical and medical device companies, with $135.11 received in 2023. These payments were reported across 127 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,105).
As a Medicare-enrolled provider, Sackstein has provided services to 6,038 Medicare beneficiaries, totaling 8,516 services with total Medicare billing of $714,235. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Trumbull, CT
- Active Since 07/18/2005
- Last Updated 11/14/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1407855927
Products in Payments
- ELIQUIS (Drug) $518.86
- XARELTO (Drug) $378.33
- Repatha (Biological) $148.96
- PRALUENT (Drug) $143.63
- MICRA (Device) $135.11
- ENTRESTO (Drug) $128.53
- BRILINTA (Drug) $128.22
- LifeVest (Device) $100.23
- PRALUENT ALIROCUMAB INJECTION (Biological) $97.51
- PRADAXA (Drug) $97.40
- NORTHERA (Drug) $56.61
- Corlanor (Drug) $51.54
- Livalo (Drug) $26.35
- OPSUMIT MACITENTAN (Drug) $23.31
- Savaysa (Drug) $22.32
- Lexiscan (Drug) $19.00
- MULTAQ (Drug) $18.74
- CardioMEMS HF System (Device) $16.65
- Cardiac Monitoring Suite (Device) $15.14
- Adempas (Drug) $12.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Trumbull
Dr. Manuel Pun, Md, MD
Cardiovascular Disease — Payments: $43,941
Cardiovascular Disease $43,941
Dr. Robert Jumper, Md, MD
Cardiovascular Disease — Payments: $15,657
Cardiovascular Disease $15,657
David Lorenz, M.d, M.D
Cardiovascular Disease — Payments: $15,579
Cardiovascular Disease $15,579
Dr. Charles Landau, Md, MD
Cardiovascular Disease — Payments: $7,204
Cardiovascular Disease $7,204
Victor Mejia, M.d, M.D
Cardiovascular Disease — Payments: $6,852
Cardiovascular Disease $6,852
Dr. Jeffrey Berman, M.d, M.D
Cardiovascular Disease — Payments: $3,299
Cardiovascular Disease $3,299